Top of page

Student/Staff Portal
Global Site Navigation

School of Medical and Health Sciences

Local Section Navigation
You are here: Main Content
  • Dr Oliver Schumacher

    Dr Oliver Schumacher

Related Contents

Dr Oliver Schumacher

Post Doctoral Research Fellow

Staff Member Details
Email: o.schumacher@ecu.edu.au
Campus: Joondalup
ORCID iD: https://orcid.org/0000-0002-8814-9429

Co-lead, Exercise and Genitourinary Cancers Research Group

Oliver is a Cancer Council WA Post-Doctoral Research Fellow at the Exercise Medicine Research Institute in the School of Medical and Health Sciences. Oliver’s research focuses on the role of exercise medicine to reduce the risk of cancer recurrence and improve survival by developing a better understanding of how exercise can influence a patient’s response to treatment.

Background

Oliver completed his PhD in exercise oncology at Edith Cowan University where he investigated the role of exercise as adjunct therapy during treatment for men with prostate cancer. He also has a Bachelor of Science and a Master of Science in Health Sciences and Technology from ETH Zurich (Switzerland).

Professional Memberships

  • American College of Sports Medicine (ACSM)
  • Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Awards and Recognition

  • 2023 – Prostate Cancer Foundation of Australia Priority Impact Research Award–Future Leaders
  • 2022 – Cancer Council WA Post-Doctoral Research Fellowship
  • 2021 – Helen Crowe Poster Award (1st Place) at the Asia-Pacific Prostate Cancer Conference
  • 2021 – Early Career Researcher Award from the Exercise Medicine Research Institute
  • 2019 – Early Career Mentorship Grant from the NHMRC Centre of Research Excellence in Prostate Cancer Survivorship
  • 2018 – PhD Scholarship from the NHMRC Centre of Research Excellence in Prostate Cancer Survivorship
  • 2017 – Finalist for the Young Investigator Award at EuroPrevent (now ESC Preventive Cardiology)

Research Areas and Interests

  • Exercise medicine as adjunct therapy during cancer treatment
  • Tumour vascular biology, blood flow and hypoxia
  • Patient-reported outcomes and treatment-related toxicity

An error has occurred that is preventing this content from displaying properly.

We apologise for the inconvenience that this may cause, and ask that you try again at another time.

If this problem persists, please report it to the IT Service Desk, via email: itservicedesk@ecu.edu.au or phone: +61 (08) 6304 6000 or extension 6000.

Skip to top of page